Related Experiment Video
Updated: May 5, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
Structural brain MRI abnormalities in pediatric patients with migraine
Maria A Rocca1, Roberta Messina, Bruno Colombo
1Division of Neuroscience, Neuroimaging Research Unit, Institute of Experimental Neurology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina, 60, 20132, Milan, Italy.
Abstract:
Morphometric MRI studies in adult patients with migraine have consistently demonstrated atrophy of several gray matter (GM) regions involved in pain processing. We explored the regional distribution of GM and white matter (WM) abnormalities in pediatric patients with episodic migraine and their correlations with disease clinical manifestations. Using a 3.0 T scanner, brain T2-weighted and 3D T1-weighted scans were acquired from 12 pediatric migraine patients and 15 age-matched healthy controls. GM and WM volumetric abnormalities were estimated using voxel-based morphometry (p < 0.05, family-wise error corrected). Compared to controls, pediatric migraine patients experienced a significant GM atrophy of several regions of the frontal and temporal lobes which are part of the pain-processing network. They also had an increased volume of the right putamen. The left fusiform gyrus had an increased volume in patients with aura compared to patients without aura and controls, whereas it was significantly atrophied in patients without aura when compared to the other two groups. No abnormalities of WM volume were detected. In migraine patients, regional GM atrophy was not correlated with disease duration and attack frequency, whereas a negative correlation was found between increased volume of the putamen and disease duration (r = -0.95, p < 0.05). These results show that GM morphometric abnormalities do occur in pediatric patients with migraine. The presence of such abnormalities early in the disease course, and the absence of correlation with patient clinical characteristics suggest that they may represent a phenotypic biomarker of this condition.
Insights
Pediatric migraine patients show gray matter (GM) atrophy in pain-processing areas and altered putamen volume. These early brain changes may indicate a unique migraine biomarker.
Area of Science:
- Neuroimaging
- Pediatric Neurology
- Pain Medicine
Background:
- Adult migraine studies reveal gray matter (GM) atrophy in pain-processing regions.
- Pediatric migraine's neurobiological underpinnings, particularly GM and white matter (WM) changes, require further investigation.
Purpose of the Study:
- To investigate regional GM and WM volumetric differences in pediatric episodic migraine patients.
- To correlate these brain morphometric changes with clinical disease manifestations.
Main Methods:
- Acquired 3.0 Tesla MRI scans (T2-weighted and 3D T1-weighted) from 12 pediatric migraine patients and 15 healthy controls.
- Utilized voxel-based morphometry (VBM) to assess GM and WM volume differences (p < 0.05, FWE-corrected).
Main Results:
- Pediatric migraine patients exhibited significant GM atrophy in frontal and temporal pain-processing regions.
- Increased right putamen volume was observed in patients; this correlated negatively with disease duration.
- The left fusiform gyrus showed varied volume changes based on migraine aura status.
Conclusions:
- Pediatric migraine is associated with GM morphometric abnormalities, particularly in pain-processing networks.
- These early-onset abnormalities, independent of clinical characteristics, may serve as a phenotypic biomarker for pediatric migraine.

